Overview

Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks

Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether Quince Oxymel is effective in the prevention of Migraine attacks in patients with simultaneous upper gastrointestinal dysfunction.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shiraz University of Medical Sciences
Treatments:
Propranolol
Criteria
Inclusion Criteria:

- minimum age of 18 years old

- giving a written informed consent

- having at least 2 migraine attacks per month

Exclusion Criteria:

- patients older than 70 years old

- patients with Diabetes mellitus

- patients with chronic obstructive pulmonary disease and asthma

- pregnancy

- severe depression

- patients affected by sexual disorders

- bradyarrhythmic patients

- positive history of hypersensitivity reactions to quince, ginger, propranolol or
naproxen